AI Study Notebook AI-generated
Study Guide: How to Change Your Mind
Michael Pollan
By Best Books
This AI-generated study guide is a reading aid. The source-backed recommendation record and evidence for this book live on the book page.
On this page
How to Change Your Mind — Chapter-by-Chapter Outline
Author: Michael Pollan
First published: 2018
Edition covered: First U.S. edition, How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence (Penguin Press, May 15, 2018; hardcover ISBN 978-1-59420-422-7; ebook ISBN 9780525558941). This outline covers the complete public structure of the book: an unnumbered prologue, six numbered chapters, and an epilogue. The ordered skeleton was cross-checked against the UW-Madison Libraries catalog, Wikipedia's structure list, and an ADF Library catalog PDF with contents, with edition metadata checked against Penguin Random House, Penguin Random House Higher Education, Google Books, and Open Library. No public source checked showed chapters added or removed in the 2019 U.S. paperback or English-language international paperback editions.
Central thesis
Pollan argues that classic psychedelics should be reconsidered as serious tools for studying consciousness and, under carefully controlled conditions, as possible adjuncts to psychotherapy. The book does not treat LSD, psilocybin, or 5-MeO-DMT as simple miracle drugs. Its central claim is narrower and more demanding: these substances can temporarily loosen the ordinary structures of selfhood, perception, and habit, and that loosening can become therapeutically meaningful when preparation, setting, guidance, and integration are handled with care.
The book is also a history of scientific interruption. Pollan reconstructs a first wave of psychedelic research in the 1950s and 1960s, its collision with counterculture and politics, and its later revival through cautious researchers, private funders, religious-liberty cases, and brain-imaging work. His first-person reporting is part of the method: he treats psychedelic experience as something that cannot be understood only from the outside, while repeatedly asking how subjective reports can be brought into disciplined science.
The final subject is not just drugs but the mind's usual limits. Pollan uses psychedelics, meditation, mystical experience, and neuroscience to ask whether ordinary waking consciousness is only one useful mode among several.
Can substances once treated as cultural threats become disciplined tools for healing, self-understanding, and the scientific study of consciousness?
Prologue — A New Door
Central question
Why should a skeptical, middle-aged journalist reopen the question of psychedelics after decades of cultural fear and scientific suppression?
Main argument
Two molecules as historical hinges. Pollan begins with LSD and psilocybin, the two compounds that most shape the book. LSD enters Western science through Albert Hofmann's 1938 synthesis and 1943 accidental discovery of its psychoactivity. Psilocybin enters the modern West through Indigenous Mesoamerican mushroom practices and R. Gordon Wasson's 1950s publicity. The prologue presents both molecules as agents that changed personal lives, science, religion, politics, and popular culture.
The author's starting position. Pollan is not writing as an evangelist. He grew up after the 1960s backlash, absorbed the conventional fear of LSD, and had only limited earlier experience with mushrooms. His curiosity is reawakened by several signals: reports of psilocybin easing end-of-life distress in cancer patients, a dinner conversation with a professional who quietly found LSD useful, and the 2006 Johns Hopkins study suggesting that psilocybin could reliably occasion experiences participants later regarded as spiritually significant.
A mixed method. The book announces itself as history, science journalism, memoir, and travelogue. Pollan will interview scientists and therapists, read the suppressed history, and eventually enter altered states himself. The prologue's key move is to make personal experience relevant without making it self-validating: what a trip feels like matters, but the meaning of that feeling still needs interpretation, context, and evidence.
Key ideas
- The book centers mainly on classic psychedelics, especially LSD and psilocybin.
- Pollan frames the current moment as a renaissance after a long research blackout.
- The prologue links therapeutic questions to larger questions about consciousness and the self.
- The book treats first-person psychedelic reports as data to be interpreted, not as automatic proof.
- Pollan's initial skepticism is part of the narrative design: the book asks what would change a cautious mind.
- The opening establishes a recurring tension between subjective meaning and scientific method.
Key takeaway
The prologue opens a controlled inquiry into whether psychedelics can reveal something real about suffering, consciousness, and the limits of ordinary perception.
Chapter 1 — A Renaissance
Central question
How did psychedelic research return to legitimacy after being driven out of mainstream science?
Main argument
2006 as a symbolic turning point. Pollan uses three events to show the shift. Albert Hofmann's hundredth birthday gathering in Basel marked a public reassessment of LSD's legacy. In the United States, the Supreme Court's ruling involving the União do Vegetal signaled that some psychedelic use could be protected in religious contexts. Most important for science, Roland Griffiths and colleagues at Johns Hopkins published a carefully designed psilocybin study that helped make psychedelic research respectable again.
The Johns Hopkins model. Griffiths is crucial because he does not look like a countercultural figure. He brings conventional scientific authority, careful screening, controlled dosing, preparation, monitors, and follow-up. The study's surprising claim is that a drug session can produce an experience with lasting personal and spiritual significance, and that such experiences can be studied without endorsing any particular religious interpretation.
The bridge figures. Pollan follows the people who kept knowledge alive during the blackout: Bill Richards, who had worked in the older Spring Grove research program; Bob Jesse, who cared about spiritually significant experience; Rick Doblin, who founded MAPS; and other therapists and funders who believed useful knowledge had been lost. The renaissance depends on people who know both the old psychedelic underground and the new institutional rules.
Mysticism enters the laboratory. The chapter treats William James as a guide to mystical experience, especially the features of ineffability, noetic quality, transience, and passivity. Pollan's point is not that science proves religious claims. It is that experiences people call mystical have recurring features and measurable aftereffects, so psychology and neuroscience cannot dismiss them merely because they are hard to describe.
Key ideas
- The renaissance begins by making psychedelic research look careful, clinical, and institutionally credible.
- Johns Hopkins becomes a major site because Griffiths combines curiosity with conventional scientific discipline.
- The chapter distinguishes studying mystical-type experiences from validating theological claims.
- Set, setting, preparation, and support are part of the research model, not optional decoration.
- The revival depends on both mainstream researchers and outsiders who preserved old methods.
- Pollan presents the 2006 psilocybin paper as a hinge between the first wave and the second wave.
Key takeaway
The psychedelic renaissance becomes possible when researchers find a way to study extraordinary subjective experiences with ordinary scientific safeguards.
Chapter 2 — Natural History: Bemushroomed
Central question
What are psilocybin mushrooms, how did they enter modern Western consciousness, and what is lost when a sacrament becomes a research molecule?
Main argument
From molecule back to organism. Modern trials use synthetic psilocybin because it is pure, measurable, and legally manageable. Pollan reverses that abstraction by going mushroom hunting with the mycologist Paul Stamets. The chapter treats Psilocybe mushrooms not only as drug delivery systems but as living organisms with ecological histories, confusing taxonomy, and cultural meanings.
Wasson, María Sabina, and the cost of discovery. R. Gordon Wasson's 1957 Life article introduced millions of readers to Mazatec mushroom ceremonies. Pollan presents that event as both historical breakthrough and cultural damage. Wasson helped reveal psilocybin to Western science, but his reporting exposed María Sabina and Huautla de Jiménez to outsiders, tourism, commercialization, and local backlash. The chapter therefore complicates the romance of discovery: Western scientific knowledge often arrives through appropriation and disruption.
Hofmann and the chemical afterlife of the mushroom. After Wasson sent specimens to Albert Hofmann, Hofmann isolated psilocybin and psilocin and produced synthetic psilocybin. That step makes modern research possible, but it also separates the compound from ceremony, ecology, and Indigenous use. Pollan keeps both facts in view: purification enables controlled science while narrowing the frame.
Why would a mushroom make psilocybin? The chapter surveys speculative theories about the evolutionary function of psilocybin. It may deter insects, alter animal behavior, or indirectly aid dispersal, but the evidence is incomplete. Pollan also treats the "stoned ape" hypothesis as imaginative but highly speculative. Its importance in the chapter is less as settled biology than as an example of how psilocybin invites large claims about language, culture, and human consciousness.
The coda: a modest first experiment. Pollan's own mushroom experience at home is gentler than later underground sessions. It changes the vividness of plants, perception, and the sense of relation to the living world, but it does not yet deliver a complete dissolution of self. The coda prepares a recurring lesson: psychedelics may make ordinary reality strange enough to be noticed again.
Key ideas
- Synthetic psilocybin is practical for research but abstracts the molecule from the mushroom.
- Wasson's publication opened a path for science while harming the community and healer he publicized.
- María Sabina becomes a central example of the unequal exchange between Indigenous practice and Western curiosity.
- Hofmann's isolation of psilocybin links mushroom ceremony to laboratory pharmacology.
- Claims about psilocybin's evolutionary role remain speculative.
- Pollan treats his first mushroom experience as perceptual and relational more than clinical.
Key takeaway
The chapter shows that psilocybin is at once a molecule, a mushroom product, a sacrament, an ecological puzzle, and a case study in the costs of cultural translation.
Chapter 3 — History: The First Wave
Central question
What did the first generation of psychedelic researchers think they had found, and why did that field collapse?
Main argument
The promise. After Sandoz made LSD available to researchers, psychiatrists first understood it as a psychotomimetic, a drug that seemed to mimic psychosis. Clinicians took LSD themselves to better understand patients with schizophrenia or severe mental distress. This led into neurochemical questions about serotonin, receptors, and the biological basis of mind.
From psychosis model to therapy model. Researchers such as Humphry Osmond, Abram Hoffer, Sidney Cohen, Betty Eisner, Oscar Janiger, and Stanislav Grof began to see that the experience itself, not just the molecule's pharmacology, might be therapeutic. In alcoholism studies, LSD seemed less like a chemical cure than a catalyst for a dramatic reorientation. The vocabulary shifted from psychotomimetic to psycholytic and then psychedelic, emphasizing mind-loosening and mind-manifesting effects.
Al Hubbard and set and setting. Pollan gives unusual weight to Al Hubbard, an eccentric lay figure who helped spread high-dose psychedelic therapy. Hubbard's influence is methodological: he understood that the room, music, guide, expectations, and symbolic atmosphere could shape the session. The chapter treats set and setting as one of the first wave's durable discoveries.
The crack-up. Timothy Leary and Richard Alpert move the story from laboratory to media spectacle. The Harvard Psilocybin Project, the Concord Prison Experiment, and the broader effort to democratize psychedelic experience blur research, spirituality, celebrity, and cultural revolt. Pollan does not make Leary the sole cause of the collapse, but he makes him the figure through whom scientific weakness, public fear, and political backlash converge.
Regulation and amnesia. By the late 1960s and early 1970s, LSD had become identified with youth rebellion, antiwar politics, alarming media stories, and uncontrolled use. Regulators halted studies, journals became wary, funding disappeared, and psychedelics were placed in Schedule I. The chapter's coda is a loss narrative: promising but uneven research was not refined; it was largely abandoned.
Key ideas
- LSD entered psychiatry before researchers had a stable model for what it did.
- Early researchers shifted from treating psychedelics as temporary psychosis to treating them as possible tools for psychotherapy.
- The first wave produced the enduring importance of set, setting, guides, music, preparation, and follow-up.
- Al Hubbard's influence shows how much practical psychedelic knowledge came from outside formal academia.
- Timothy Leary's behavior damaged the field, but politics, media panic, poor controls, and recreational spread also mattered.
- The research shutdown caused scientific amnesia: later researchers had to rediscover practices that earlier clinicians had already developed.
Key takeaway
The first wave found genuine therapeutic and scientific possibilities but lost credibility when weak research boundaries, cultural upheaval, and political panic became inseparable.
Chapter 4 — Travelogue: Journeying Underground
Central question
What can Pollan learn by undergoing guided psychedelic sessions outside the legal research system?
Main argument
Why underground guides matter. Pollan wants direct experience but cannot easily join a clinical trial as a healthy volunteer. He therefore enters the underground network of guides descended partly from older psychedelic therapists. The chapter emphasizes that illegality has not eliminated psychedelic practice; it has pushed it into informal systems with variable quality, discretion, and inherited norms.
Trip one: LSD. Pollan's LSD session with the guide he calls Fritz is preceded by holotropic breathwork, medical anxiety, and careful preparation. The session includes eyeshades, music, a protected room, and instructions to surrender to the experience. Pollan encounters emotionally charged imagery involving his wife, son, parents, siblings, and his fear around the heart. His ego is loosened rather than erased. The insights sound simple when spoken afterward, but they feel emotionally authoritative inside the session.
Trip two: psilocybin. With the guide he calls Mary, Pollan experiences a stronger and less controllable journey. Music and eyeshades become decisive. The trip moves through alien digital imagery, bodily vulnerability, death, ancestors, mourning, and a moment in which the ordinary "I" seems to scatter without needing to be reassembled. This is the chapter's clearest account of ego dissolution before the toad session. Pollan emerges with the sense that the self can be less defended, less neurotic, and more generous.
Trip three: 5-MeO-DMT. The final session, guided by Rocío, involves vaporized 5-MeO-DMT associated with the Sonoran Desert toad. It is brief, violent, and nearly impossible for Pollan to narrate in ordinary sequence. He uses metaphors of propulsion, terror, cosmic reversal, annihilation, and rebirth. The important aftermath is not doctrinal certainty but gratitude, fatherhood, and the felt possibility of being less dominated by doing.
The limits of trip reports. Pollan treats these sessions as experiential evidence, not clinical proof. They help him understand what patients and volunteers describe, why guides matter, why integration matters, and why language often fails. They also show the risk of overreading: the content of a psychedelic session can be emotionally powerful without being straightforwardly true.
Key ideas
- Underground practice preserves knowledge but lacks consistent public accountability.
- Preparation, trust, music, eyeshades, and post-session integration shape the experience.
- LSD gives Pollan emotional access while leaving his ego largely intact.
- Psilocybin produces a stronger confrontation with death, family, and self-dissolution.
- 5-MeO-DMT is presented as rapid, overwhelming, and resistant to narrative.
- The chapter makes Pollan's later discussion of therapy more concrete: he now knows what guided surrender can feel like.
Key takeaway
The travelogue shows that psychedelic experience is not just a pharmacological event; it is a guided encounter with expectation, memory, fear, relationship, and the structures of self.
Chapter 5 — The Neuroscience: Your Brain on Psychedelics
Central question
What do psychedelics appear to do in the brain, and how might those changes explain ego dissolution, creativity, and therapeutic effects?
Main argument
The chemical doorway. Pollan begins with the family resemblance between classic psychedelics and serotonin. LSD, psilocin, and 5-MeO-DMT interact strongly with the 5-HT2A receptor, especially in the cortex. This receptor story explains part of the entry mechanism, but Pollan stresses that receptor binding alone does not explain the subjective depth of a trip, the sense of meaning, or the therapeutic aftereffects.
Robin Carhart-Harris and the default mode network. At Imperial College London, Carhart-Harris and colleagues use brain imaging to examine psychedelic states. A surprising early result is that psilocybin does not simply turn the brain up. Activity decreases in key hubs, especially regions associated with the default mode network. Pollan presents the DMN as a high-level organizing system involved in autobiographical memory, self-reference, mental time travel, social judgment, and the construction of the ego.
Ego as an achievement and a constraint. The chapter does not treat the ego as merely bad. The self organizes experience, supports planning, and lets humans maintain identity across time. But the same system can become overly rigid. When the DMN loosens, other brain networks communicate in less habitual ways. Subjectively, this may feel like ego dissolution, novel association, awe, or contact with normally filtered material.
The entropic brain. Carhart-Harris's entropic brain hypothesis gives Pollan a model for why psychedelics might help mental disorders marked by rigid loops. Depression, addiction, obsession, and anxiety can be understood partly as overlearned patterns. Psychedelics temporarily increase entropy: more disorder, flexibility, and cross-talk. Pollan's snow-globe metaphor captures the proposed therapeutic mechanism: shake the system, let fixed patterns become fluid, then allow new settling.
Children, creativity, and "lantern" attention. Alison Gopnik's work on child consciousness helps Pollan connect psychedelics to broad, exploratory attention. Adult cognition often works like a spotlight: efficient, narrow, goal-directed. Child cognition is more lantern-like: diffuse, receptive, and exploratory. Psychedelics may briefly reopen a similar mode, supporting creative association but also reducing ordinary control.
Key ideas
- Classic psychedelics act strongly through serotonin-related 5-HT2A receptors, but the receptor story is not the whole explanation.
- Brain imaging helped make psychedelic states scientifically discussable again.
- The default mode network is central to Pollan's account of selfhood and ego dissolution.
- Psychedelics may reduce top-down control and allow unusual communication among brain systems.
- The entropic brain model links psychedelics to flexibility, creativity, and possible relief from rigid mental habits.
- Pollan avoids reducing meaning to mechanism: a neural correlate does not exhaust the experience's personal significance.
Key takeaway
The neuroscience chapter argues that psychedelics may work by temporarily relaxing the brain systems that maintain the ordinary self, thereby increasing flexibility in perception, emotion, and thought.
Chapter 6 — The Trip Treatment: Psychedelics in Psychotherapy
Central question
How might guided psychedelic sessions help people facing death, addiction, or depression?
Main argument
The treatment is not just the drug. Pollan repeatedly emphasizes that psychedelic therapy is a package: screening, preparation, intention, a supported dosing session, music, eyeshades, trained guides, and integration. The drug opens a window, but the therapeutic question is what happens inside that window and how the patient makes use of it afterward.
One: dying. The chapter's central case is Patrick Mettes, a participant in the NYU psilocybin cancer trial. Mettes's session is presented as a vivid confrontation with death, family, love, and unfinished life. Pollan connects this to the broader NYU and Johns Hopkins cancer studies, where many participants reported reduced anxiety and depression after high-dose psilocybin sessions. The proposed mechanism is not distraction from death but a changed relation to self, body, fear, and connection.
Two: addiction. Pollan next turns to smoking and alcoholism. Matthew Johnson's Johns Hopkins smoking study is small and preliminary, but its abstinence numbers are striking enough to demand further research. Pollan also links this work to older LSD alcoholism studies and a later meta-analysis. The core idea is that addiction is not only chemical dependence but a narrowed pattern of attention and behavior. A psychedelic session can make an already-known truth emotionally real: the habit is no longer aligned with what matters.
Three: depression. The depression section follows Carhart-Harris's early psilocybin work with treatment-resistant patients. Pollan is careful about small samples and relapse, but he treats the reports seriously. Patients often describe depression as disconnection from self, others, senses, and feeling. Psilocybin may temporarily interrupt rumination and allow painful emotions to be encountered rather than avoided.
Coda: Going to Meet My Default Mode Network. Pollan closes the chapter by connecting psychedelics with meditation and neurofeedback. In the lab, he observes how self-referential thought can register as activity in default-mode-related regions, while present-centered attention quiets the same pattern. The coda broadens the book's argument: psychedelics are one way to loosen the grip of the ego, but not the only one.
Key ideas
- Psychedelic therapy depends on context, relationship, and integration as much as dose.
- End-of-life anxiety is treated by changing the patient's relationship to death, not by denying death.
- Addiction studies suggest that psychedelics can make ordinary insights newly consequential.
- Depression is framed partly as rigid, self-reinforcing rumination and disconnection.
- The early clinical results are promising but preliminary, often small, and not a license for casual use.
- Meditation and psychedelics converge in Pollan's account because both can quiet self-referential processing.
Key takeaway
The therapeutic promise of psychedelics lies in their capacity to disrupt rigid patterns of self and meaning, but that disruption becomes treatment only inside a disciplined therapeutic container.
Epilogue — In Praise of Neural Diversity
Central question
What should society do with the psychedelic renaissance, and how has Pollan's own understanding changed?
Main argument
The movement becomes visible. Pollan visits the 2017 Psychedelic Science conference in Oakland, where scientists, psychiatrists, therapists, funders, religious practitioners, entrepreneurs, and psychonauts occupy the same public space. The scene signals that psychedelics are no longer only underground or countercultural; they are entering medicine, philanthropy, media, and policy debates.
Institutional promise and institutional friction. The epilogue stresses that medicalization will be difficult. Classic psychedelics are not conventional daily pharmaceuticals, patents are limited, sessions require expensive human support, and regulators must evaluate treatments in which subjective experience may be part of the mechanism. Pollan also warns that unregulated enthusiasm can repeat older mistakes. The book's implied path is neither blanket prohibition nor casual legalization, but trained guidance, careful screening, and public accountability.
Neural diversity. Pollan's final concept is that ordinary waking consciousness is useful but not exhaustive. Psychedelics, meditation, dreams, awe, and other altered states can reveal that the self is constructed and that perception is filtered. This does not mean every altered state is wise. It means a culture may benefit from safe, structured access to more than one mode of mind.
Integration over revelation. Pollan ends without becoming a religious convert or a drug advocate in the simple sense. He has had experiences that changed his sense of death, nature, family, and mind, but he treats lasting value as something that must be integrated through practice, reflection, and relationship. A trip is an opening, not a completed life.
Key ideas
- By 2017, psychedelic research has become public enough to attract mainstream psychiatry, investors, and media.
- Medicalization raises practical problems: training, ethics, cost, patents, access, and regulation.
- Pollan does not argue that psychedelics are appropriate for everyone.
- The concept of neural diversity reframes altered states as potentially useful variations in consciousness.
- Integration is the safeguard against confusing intensity with wisdom.
- The epilogue returns the reader from extraordinary experience to ordinary life, asking what can be carried back.
Key takeaway
The book closes by arguing for cautious, structured access to altered states as a way to expand medicine, science, and ordinary self-understanding without repeating the excesses of the first wave.
The book's overall argument
- Prologue (A New Door) — Pollan establishes the puzzle: feared psychedelic molecules may hold scientific and therapeutic value that was obscured by cultural panic.
- Chapter 1 (A Renaissance) — The revival begins when rigorous researchers, older guides, and private funders bring psychedelic experience back into respectable science.
- Chapter 2 (Natural History: Bemushroomed) — Psilocybin is rooted in fungal ecology and Indigenous ceremony, so modern research inherits both scientific promise and cultural debt.
- Chapter 3 (History: The First Wave) — The earlier research wave found real possibilities but collapsed when therapy, evangelism, weak boundaries, politics, and media panic converged.
- Chapter 4 (Travelogue: Journeying Underground) — Pollan's guided sessions show from the inside why set, setting, surrender, and integration matter.
- Chapter 5 (The Neuroscience: Your Brain on Psychedelics) — Brain imaging and the default mode network offer a plausible mechanism for ego dissolution and cognitive flexibility.
- Chapter 6 (The Trip Treatment: Psychedelics in Psychotherapy) — Clinical work suggests that psychedelic-assisted therapy may help with dying, addiction, and depression by loosening rigid patterns of fear and self-reference.
- Epilogue (In Praise of Neural Diversity) — The book argues for a cautious public future in which altered states are studied, guided, integrated, and treated as part of the mind's range.
Common misunderstandings
Misunderstanding: The book says psychedelics are magic cures.
Pollan's account is more conditional. The promising outcomes occur in prepared, supported, and integrated sessions, often with extensive screening. The book repeatedly distinguishes therapeutic use from unsupervised intoxication.
Misunderstanding: Pollan is simply arguing for recreational legalization.
The book is mainly about science, therapy, and consciousness. Pollan is open to expanded access but emphasizes trained guides, safeguards, and institutional responsibility rather than a simple consumer market.
Misunderstanding: Timothy Leary alone destroyed psychedelic science.
Leary is important, but Pollan presents a broader failure involving media panic, weak research standards, political fear, uncontrolled supply, generational conflict, and the difficulty of separating medical use from cultural revolt.
Misunderstanding: Mystical experience is treated as proof of religion.
Pollan treats mystical-type experience as a psychological phenomenon with recurring features and possible therapeutic consequences. The book does not require the reader to accept supernatural claims.
Misunderstanding: Neuroscience has fully explained psychedelic therapy.
The default mode network and entropic brain models are presented as promising frameworks, not complete explanations. Pollan keeps a gap between neural correlates and lived meaning.
Misunderstanding: The content of a trip should always be believed literally.
The book gives psychedelic imagery emotional seriousness without treating it as automatic truth. Integration means interpreting the experience, not obeying it uncritically.
Misunderstanding: Psychedelics are safe for everyone.
Pollan repeatedly notes the need for screening, support, and caution, especially around psychosis risk, medical vulnerability, panic, unsafe guides, and unstable settings.
Central paradox / key insight
The book's central paradox is that substances associated with irrationality, loss of control, and 1960s panic may be valuable precisely because they interrupt ordinary control. The same quality that makes psychedelics culturally threatening--their power to loosen settled identities, assumptions, and institutions--is what may make them useful in therapy and consciousness research.
The key insight is therefore not that the ego is bad or that ordinary consciousness is false. It is that the ordinary self is a useful construction that can become too rigid. A temporary, well-supported relaxation of that construction may help some people see death, addiction, depression, relationships, and nature from a less defended perspective.
The mind may need both stability and occasions of carefully held instability.
Important concepts
Psychedelic
Pollan uses the term in its etymological sense of "mind manifesting": a substance or experience that brings normally hidden mental contents, patterns, and possibilities into awareness.
LSD
Lysergic acid diethylamide, first synthesized by Albert Hofmann in 1938 and discovered to be psychoactive in 1943. It is central to both the first research wave and the 1960s backlash.
Psilocybin / psilocin
Psilocybin is the psychoactive compound associated with many "magic mushrooms"; psilocin is closely related and active in the body. Pollan treats psilocybin as the key molecule of the modern clinical renaissance.
5-MeO-DMT
A fast-acting, intense psychedelic compound found in some plants and in the venom of the Sonoran Desert toad. Pollan presents it as especially resistant to ordinary narration.
Set and setting
The user's mindset and the physical, social, musical, symbolic, and interpersonal environment of the session. The book treats set and setting as central determinants of psychedelic experience.
Guide / sitter
The trained or experienced person who prepares, accompanies, protects, and helps integrate a psychedelic session. Pollan treats the guide as part of the therapeutic method.
Integration
The process of making sense of a psychedelic experience after the acute effects end, connecting images and insights to ordinary life, therapy, relationships, and practice.
Mystical-type experience
A structured category of experience marked by features such as unity, sacredness, ineffability, deep meaning, altered time, and positive mood. Pollan emphasizes that such experiences can be studied without settling metaphysical questions.
Noetic quality
William James's term for the sense that a mystical experience discloses knowledge or truth. Pollan treats this feeling as powerful but also in need of interpretation.
Ego dissolution
The temporary weakening or disappearance of the ordinary sense of being a separate, controlling self. The book links ego dissolution to mystical experience, therapeutic change, and decreased default mode network activity.
Default mode network
A set of interacting brain regions active in self-reference, autobiographical memory, mental time travel, and mind-wandering. Pollan uses it as a neural framework for understanding ego and rumination.
5-HT2A receptor
A serotonin receptor strongly implicated in the action of classic psychedelics. It is the chemical entry point for many of the brain-level effects discussed in the book.
Entropic brain
Robin Carhart-Harris's hypothesis that psychedelic states increase the entropy or flexibility of brain activity, loosening rigid patterns and allowing unusual connections.
Psychotomimetic
An early term for psychedelics meaning psychosis-mimicking. It reflects the first psychiatric model of LSD before researchers shifted toward therapeutic and mystical interpretations.
Psycholytic
A therapeutic model using lower doses to loosen the mind and support psychoanalytic work. The term means mind-loosening.
Psychedelic therapy
A model in which a psychedelic session is embedded in preparation, guided dosing, and integration. The drug is not treated as a stand-alone cure.
Neural diversity
Pollan's term for valuing multiple modes of consciousness rather than treating ordinary waking awareness as the only legitimate one.
Schedule I
The U.S. legal classification that defines certain drugs as having high abuse potential and no accepted medical use. Pollan treats Schedule I status as a major obstacle to research and access.
Holotropic breathwork
A non-drug method developed after psychedelic therapy was suppressed, using intense breathing, music, and support to induce altered states. Pollan encounters it as a bridge between older psychedelic practice and underground guiding.
References and Web Links
Primary book and edition information
- Michael Pollan. How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. Penguin Press, 2018.
- Penguin Random House official book page
- Penguin Random House Higher Education edition metadata, including ebook and hardcover formats
- Google Books record
- Open Library edition record
- UW-Madison Libraries catalog record with contents
- Wikipedia overview and structure list
- ADF Library catalog PDF with table-of-contents listing
- Michael Pollan's official page for the book
Background and overview
- Bennington College excerpt from "A New Door"
- Bioneers excerpt/adaptation from Pollan on the psychedelic renaissance
- Michael Pollan, "The Trip Treatment," The New Yorker, 2015
- Michael Pollan, "My Adventures With the Trip Doctors"
- Heffter Research Institute note on the 2010 New York Times article that drew Pollan's attention
- TIME interview with Pollan about the psychedelic renaissance and the Netflix adaptation
Psychedelic research, neuroscience, and therapy
- Roland R. Griffiths, William A. Richards, Una McCann, and Robert Jesse. "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance." Psychopharmacology, 2006.
- Robin L. Carhart-Harris et al. "Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin." PNAS, 2012.
- Robin L. Carhart-Harris et al. "The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs." Frontiers in Human Neuroscience, 2014.
- Stephen Ross et al. "Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer." Journal of Psychopharmacology, 2016.
- Matthew W. Johnson et al. "Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction." Journal of Psychopharmacology, 2014.
- Teri S. Krebs and Pål-Ørjan Johansen. "Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials." Journal of Psychopharmacology, 2012.
- Robin L. Carhart-Harris et al. "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study." The Lancet Psychiatry, 2016.
Additional chapter summaries and study resources
These are secondary summaries and should be used alongside, rather than instead of, the original book.